An aid in prevention of TGE, rotaviral diarrhea, colibacillosis and enterotoxemia in nursing pigs of vaccinated sows/gilts. Unique eight-way scours protection. Freeze-dried MLV vaccine with bacterin/ toxoid diluent.
PORCINE ROTAVIRUS – TRANSMISSIBLE GASTROENTERITIS VACCINE
Clostridium Perfringens Type C – Escherichia Coli bacterin-Toxoid
For the vaccination of healthy pregnant swine, to provide passive protection to their nursing pigs against disease caused by eight pathogens: Rotavirus (2 modified-live G serotypes 5 and 4 of serogroup A rotavirus), TGE (transmissible gastroenteritis), Colibacillosis (Escherichia coli pilus antigens K88, K99, F41 and 987P) and Enterotoxemia (Clostridium perfringens type C).
Safe and effective against neonatal rotaviral diarrhea, TGE, enterotoxemia and colibacillosis.
- Aids in the prevention of enterotoxemia to reduce death loss and scours1
- 70–100% protection against C. perfringens type C challenged litters1
- Four major E. coli pilus types; K88, K99, 987P and F41; for comprehensive protection against colibacillosis1
- Unique modified-live TGEV strain; acid-resistance selected for best gut-level protection1
- First USDA-licensed vaccine with two serotypes of serogroup A rotavirus, G5 (A1) and G4 (A2), for best protection1
- Up to 100% protection from mortality in rotavirus challenge of vaccinated sow litters1
For additional information, please see the product label.
- Data on file, Merck Animal Health.